ArticleCancer research communications2025

Evaluating Gene Fusions as Prognostic Biomarkers and Therapeutic Targets in Immune Checkpoint Blockade-Treated Advanced Melanoma: A Retrospective Analysis.

Guadalupe Nibeyro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.